AFFF cancer lawsuit

AFFF Lawsuits Highlight PFAS Forever Chemical's Impact on Firefighters and the Environment

AFFF multi-district litigation explores the consequences of PFAS exposure among firefighters and environmental concerns affecting millions of citizens

Saturday, March 23, 2024 - Firefighting Foam lawsuits have been consolidated into multidistrict litigation (MDL) in the District of South Carolina, to address the numerous claims in a unified manner. As of early 2024, the MDL comprises over 6,700 cases, highlighting the scale of concern regarding AFFF exposure. Defendants in the litigation include major chemical manufacturers like 3M Co., Chemours, Chemguard Inc., DuPont, and Tyco Fire Products, reflecting the widespread production and distribution of AFFF. Plaintiffs, primarily firefighters, airport workers, and U.S. military veterans, seek compensation for health conditions they attribute to AFFF exposure, including various types of cancer and other serious ailments. The litigation underscores a critical public health issue, focusing on the balance between the need for effective firefighting tools and the imperative to protect those who use them from harmful chemical exposures. As the cases proceed, they not only represent individual quests for justice but also contribute to a broader discourse on environmental health, chemical safety, and the responsibilities of chemical manufacturers to ensure their products do not pose undue risks to human health or the environment.

Deeply ingrained in the chemical makeup of AFFF and its widespread application in firefighting, the Aqueous Film-Forming Foam (AFFF) case captures a wide-ranging and intricate topic. To create a barrier between the fuel and the air to effectively smother the fire and stop its spread, AFFF is a type of firefighting foam that is specially made for putting out flammable liquid fires, such as those using oil and gasoline. However, there is a major disadvantage to this effectiveness. The foam is made up of per- and poly-fluoroalkyl substances (PFAS), a class of synthetic chemicals that have been around for a century and utilized in a wide range of consumer goods and industrial uses because they don't melt, run, or break down easily. Environmentally persistent poly-fluoroalkyl substances, or "forever chemicals," Concerns have been raised by firemen and military people who have traditionally been exposed to AFFF in the course of their work about these chemicals since they have been connected to several health problems, such as cancer, thyroid disorders, and effects on the immune system. Numerous AFFF lawsuits have been filed as a result of this exposure, claiming that the makers of AFFF intentionally put people at risk by not providing enough warning about the risks related to PFAS.

The AFFF MDL is more than just a legal case; it marks a turning point in the continuing conversation about occupational and environmental health. Using these litigations, plaintiffs and their supporters shed focus on the more general problem of chemical safety and corporate accountability, pushing for increased openness and more stringent rules about dangerous materials. The decisions made in these cases may establish important legal precedents that could result in stricter regulation of PFAS and other dangerous substances in firefighting foams as well as other consumer goods and industrial uses. This litigation also underscores the importance of scientific research in guiding policy and legal frameworks, as emerging studies continue to reveal the extent of PFAS's impact on human health and the environment. As society grapples with the consequences of decades-long exposure to these chemicals, the AFFF MDL serves as a critical juncture, prompting a reevaluation of how we balance technological advancements with the need to protect public health and the environment for current and future generations.

Information provided by AFFFLawsuitCenter.com, a website devoted to providing news about AFFF and PFAS cancer, lymphoma and leukaemia claims, including a free no-cost, no-obligation AFFF Lawsuit Claim.

More Recent AFFF Lawsuit News:

View all AFFF Lawsuit News

No-Cost, No-Obligation Claim Review for Persons or Families of Persons Who Developed Cancer, Lymphoma or Leukaemia After Exposure to Firefighting Foam

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The firm has represented thousands of persons in these and other products liability litigation, including DePuy hip replacement systems, which settled for $2.5 billion and Pradaxa internal bleeding, which settled for $650 million. The Onder Law Firm won over $300 million in four to date and other law firms throughout the nation often seek its experience and expertise on complex litigation.


Privacy Notice: This site uses cookies for advertising, analytics and to improve our site services. By continuing to use our site, you agree to our use of cookies. For more information, see our cookie and privacy policy.